Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Issue Cover for Volume 11, Number 9—September 2005

Volume 11, Number 9—September 2005

[PDF - 7.89 MB - 171 pages]

Perspective

Canine Rabies Ecology in Southern Africa [PDF - 206 KB - 6 pages]
J. Bingham

Rabies is a widespread disease in African domestic dogs and certain wild canine populations. Canine rabies became established in Africa during the 20th century, coinciding with ecologic changes that favored its emergence in canids. I present a conceptual and terminologic framework for understanding rabies ecology in African canids. The framework is underpinned by 2 distinct concepts: maintenance and persistence. Maintenance encompasses the notion of indefinite transmission of infection within a local population and depends on an average transmission ratio >1. Maintenance in all local populations is inherently unstable, and the disease frequently becomes extinct. Persistence, the notion of long-term continuity, depends on the presence of rabies in >1 local population within the canine metapopulation at any time. The implications for understanding rabies ecology and control are reviewed, as are previous studies on rabies ecology in African canids.

EID Bingham J. Canine Rabies Ecology in Southern Africa. Emerg Infect Dis. 2005;11(9):1337-1342. https://doi.org/10.3201/eid1109.050172
AMA Bingham J. Canine Rabies Ecology in Southern Africa. Emerging Infectious Diseases. 2005;11(9):1337-1342. doi:10.3201/eid1109.050172.
APA Bingham, J. (2005). Canine Rabies Ecology in Southern Africa. Emerging Infectious Diseases, 11(9), 1337-1342. https://doi.org/10.3201/eid1109.050172.
Synopses

Achieving Operational Hydrologic Monitoring of Mosquitoborne Disease [PDF - 482 KB - 8 pages]
J. Shaman and J. F. Day

Mosquitoes and mosquitoborne disease transmission are sensitive to hydrologic variability. If local hydrologic conditions can be monitored or modeled at the scales at which these conditions affect the population dynamics of vector mosquitoes and the diseases they transmit, a means for monitoring or modeling mosquito populations and mosquitoborne disease transmission may be realized. We review how hydrologic conditions have been associated with mosquito abundances and mosquitoborne disease transmission and discuss the advantages of different measures of hydrologic variability. We propose that the useful application of any measure of hydrologic conditions requires additional consideration of the scales for both the hydrologic measurement and the vector control interventions that will be used to mitigate an outbreak of vectorborne disease. Our efforts to establish operational monitoring of St. Louis encephalitis virus and West Nile virus transmission in Florida are also reviewed.

EID Shaman J, Day JF. Achieving Operational Hydrologic Monitoring of Mosquitoborne Disease. Emerg Infect Dis. 2005;11(9):1343-1350. https://doi.org/10.3201/eid1109.050340
AMA Shaman J, Day JF. Achieving Operational Hydrologic Monitoring of Mosquitoborne Disease. Emerging Infectious Diseases. 2005;11(9):1343-1350. doi:10.3201/eid1109.050340.
APA Shaman, J., & Day, J. F. (2005). Achieving Operational Hydrologic Monitoring of Mosquitoborne Disease. Emerging Infectious Diseases, 11(9), 1343-1350. https://doi.org/10.3201/eid1109.050340.
Research

Variant Creutzfeldt-Jakob Disease Death, United States [PDF - 179 KB - 4 pages]
E. D. Belay et al.

The only variant Creutzfeldt-Jakob disease (vCJD) patient identified in the United States died in 2004, and the diagnosis was confirmed by analysis of autopsy tissue. The patient likely acquired the disease while growing up in Great Britain before immigrating to the United States in 1992. Additional vCJD patients continue to be identified outside the United Kingdom, including 2 more patients in Ireland, and 1 patient each in Japan, Portugal, Saudi Arabia, Spain, and the Netherlands. The reports of bloodborne transmission of vCJD in 2 patients, 1 of whom was heterozygous for methionine and valine at polymorphic codon 129, add to the uncertainty about the future of the vCJD outbreak.

EID Belay ED, Sejvar JJ, Shieh W, Wiersma ST, Zou W, Gambetti P, et al. Variant Creutzfeldt-Jakob Disease Death, United States. Emerg Infect Dis. 2005;11(9):1351-1354. https://doi.org/10.3201/eid1109.050371
AMA Belay ED, Sejvar JJ, Shieh W, et al. Variant Creutzfeldt-Jakob Disease Death, United States. Emerging Infectious Diseases. 2005;11(9):1351-1354. doi:10.3201/eid1109.050371.
APA Belay, E. D., Sejvar, J. J., Shieh, W., Wiersma, S. T., Zou, W., Gambetti, P....Schonberger, L. B. (2005). Variant Creutzfeldt-Jakob Disease Death, United States. Emerging Infectious Diseases, 11(9), 1351-1354. https://doi.org/10.3201/eid1109.050371.

Potential Impact of Antiviral Drug Use during Influenza Pandemic [PDF - 559 KB - 8 pages]
R. Gani et al.

The recent spread of highly pathogenic strains of avian influenza has highlighted the threat posed by pandemic influenza. In the early phases of a pandemic, the only treatment available would be neuraminidase inhibitors, which many countries are considering stockpiling for pandemic use. We estimate the effect on hospitalization rates of using different antiviral stockpile sizes to treat infection. We estimate that stockpiles that cover 20%–25% of the population would be sufficient to treat most of the clinical cases and could lead to 50% to 77% reductions in hospitalizations. Substantial reductions in hospitalization could be achieved with smaller antiviral stockpiles if drugs are reserved for persons at high risk.

EID Gani R, Hughes H, Fleming D, Griffin T, Medlock J, Leach S. Potential Impact of Antiviral Drug Use during Influenza Pandemic. Emerg Infect Dis. 2005;11(9):1355-1362. https://doi.org/10.3201/eid1109.041344
AMA Gani R, Hughes H, Fleming D, et al. Potential Impact of Antiviral Drug Use during Influenza Pandemic. Emerging Infectious Diseases. 2005;11(9):1355-1362. doi:10.3201/eid1109.041344.
APA Gani, R., Hughes, H., Fleming, D., Griffin, T., Medlock, J., & Leach, S. (2005). Potential Impact of Antiviral Drug Use during Influenza Pandemic. Emerging Infectious Diseases, 11(9), 1355-1362. https://doi.org/10.3201/eid1109.041344.

Fluoroquinolone-resistant Escherichia coli, Indonesia [PDF - 127 KB - 7 pages]
K. Kuntaman et al.

In a recent, population-based survey of 3,996 persons in Indonesia, fluoroquinolone (FQ)-resistant Escherichia coli was prevalent in the fecal flora of 6% of patients at hospital admission and 23% of patients at discharge, but not among healthy relatives or patients visiting primary healthcare centers (2%). Molecular typing showed extensive genetic diversity with only limited clonality among isolates. This finding suggests that independent selection of resistant mutants occurs frequently. FQ-resistant isolates exhibited a higher rate of spontaneous mutation, but sparser virulence profiles, than FQ-susceptible isolates from the same population. The resistant isolates belonged predominantly to phylogenetic groups A (57%) and B1 (22%) but also to the moderately virulent group D (20%). Hypervirulent strains from the B2 cluster were underrepresented (1%). Because FQ-resistant E. coli can cause disease, especially nosocomial infections in immunocompromised patients, spread of such strains must be stopped.

EID Kuntaman K, Lestari E, Severin JA, Kershof IM, Mertaniasih N, Purwanta M, et al. Fluoroquinolone-resistant Escherichia coli, Indonesia. Emerg Infect Dis. 2005;11(9):1363-1369. https://doi.org/10.3201/eid1109.041207
AMA Kuntaman K, Lestari E, Severin JA, et al. Fluoroquinolone-resistant Escherichia coli, Indonesia. Emerging Infectious Diseases. 2005;11(9):1363-1369. doi:10.3201/eid1109.041207.
APA Kuntaman, K., Lestari, E., Severin, J. A., Kershof, I. M., Mertaniasih, N., Purwanta, M....Verbrugh, H. A. (2005). Fluoroquinolone-resistant Escherichia coli, Indonesia. Emerging Infectious Diseases, 11(9), 1363-1369. https://doi.org/10.3201/eid1109.041207.

Dead Crow Density and West Nile Virus Monitoring, New York [PDF - 255 KB - 6 pages]
M. Eidson et al.

New York State used the health commerce system to monitor the number of West Nile virus (WNV) human disease cases and the density of dead crows. In each year from 2001 to 2003 and for the 3 years combined, persons living in New York counties (excluding New York City) with elevated weekly dead crow densities (above a threshold value of 0.1 dead crows per square mile) had higher risk (2.0–8.6 times) for disease caused by WNV within the next 2 weeks than residents of counties reporting fewer dead crows per square mile. This type of index can offer a real-time, relatively inexpensive window into viral activity in time for prevention and control. Changes in reporting, bird populations, and immunity may require that thresholds other than 0.1 be used in later years or in other areas.

EID Eidson M, Schmit K, Hagiwara Y, Anand M, Backenson P, Gotham I, et al. Dead Crow Density and West Nile Virus Monitoring, New York. Emerg Infect Dis. 2005;11(9):1370-1375. https://doi.org/10.3201/eid1109.040712
AMA Eidson M, Schmit K, Hagiwara Y, et al. Dead Crow Density and West Nile Virus Monitoring, New York. Emerging Infectious Diseases. 2005;11(9):1370-1375. doi:10.3201/eid1109.040712.
APA Eidson, M., Schmit, K., Hagiwara, Y., Anand, M., Backenson, P., Gotham, I....Kramer, L. (2005). Dead Crow Density and West Nile Virus Monitoring, New York. Emerging Infectious Diseases, 11(9), 1370-1375. https://doi.org/10.3201/eid1109.040712.

Dengue Virus Type 3, Brazil, 2002 [PDF - 88 KB - 6 pages]
R. Nogueira et al.

During the summer of 2002, Rio de Janeiro had a large epidemic of dengue fever; 288,245 cases were reported. A subset of 1,831 dengue hemorrhagic fever cases occurred. In this study, performed in the first half of 2002, samples from 1,559 patients with suspected cases of dengue infection were analyzed. From this total, 1,497 were obtained from patients with nonfatal cases, and 62 were obtained from patients with fatal cases. By the use of different methods, 831 (53.3%) cases, including 40 fatal cases, were confirmed as dengue infection. When virus identification was successful, dengue virus type 3 (DENV-3) was obtained in 99% of cases. Neurologic involvement was shown in 1 patient with encephalitis, confirmed by the detection of DENV-3 RNA in the cerebrospinal fluid. This explosive epidemic of DENV-3 was the most severe dengue epidemic reported in Brazil since dengue viruses were introduced in 1986.

EID Nogueira R, Schatzmayr H, Bispo de Filippis A, Barreto dos Santos F, Venâncio da Cunha R, Coelho J, et al. Dengue Virus Type 3, Brazil, 2002. Emerg Infect Dis. 2005;11(9):1376-1381. https://doi.org/10.3201/eid1109.041043
AMA Nogueira R, Schatzmayr H, Bispo de Filippis A, et al. Dengue Virus Type 3, Brazil, 2002. Emerging Infectious Diseases. 2005;11(9):1376-1381. doi:10.3201/eid1109.041043.
APA Nogueira, R., Schatzmayr, H., Bispo de Filippis, A., Barreto dos Santos, F., Venâncio da Cunha, R., Coelho, J....Miagostovich, M. (2005). Dengue Virus Type 3, Brazil, 2002. Emerging Infectious Diseases, 11(9), 1376-1381. https://doi.org/10.3201/eid1109.041043.

Trypanosomiasis Control, Democratic Republic of Congo, 1993–2003 [PDF - 204 KB - 7 pages]
P. Lutumba et al.

In the Democratic Republic of Congo (DRC), human African trypanosomiasis (HAT) reached unprecedented levels in the 1990s. To assess recent trends and evaluate control efforts, we analyzed epidemiologic and financial data collected by all agencies involved in HAT control in DRC from 1993 to 2003. Funds allocated to control populations, as well as to the population screened, doubled from 1993 to 1997 and from 1998 to 2003. The number of cases detected decreased from 26,000 new cases per year in 1998 to 11,000 in 2003. Our analysis shows that HAT control in DRC is almost completely dependent on international aid and that sudden withdrawal of such aid in 1990 had a long-lasting effect. Since 1998, control efforts intensified because of renewed donor interest, including a public-private partnership, and this effort led to a major reduction in HAT incidence. To avoid reemergence of this disease, such efforts should be sustained.

EID Lutumba P, Robays J, Bilenge C, Mesu V, Molisho D, Declercq J, et al. Trypanosomiasis Control, Democratic Republic of Congo, 1993–2003. Emerg Infect Dis. 2005;11(9):1382-1388. https://doi.org/10.3201/eid1109.041020
AMA Lutumba P, Robays J, Bilenge C, et al. Trypanosomiasis Control, Democratic Republic of Congo, 1993–2003. Emerging Infectious Diseases. 2005;11(9):1382-1388. doi:10.3201/eid1109.041020.
APA Lutumba, P., Robays, J., Bilenge, C., Mesu, V., Molisho, D., Declercq, J....Boelaert, M. (2005). Trypanosomiasis Control, Democratic Republic of Congo, 1993–2003. Emerging Infectious Diseases, 11(9), 1382-1388. https://doi.org/10.3201/eid1109.041020.

Persistence of Resistant Staphylococcus epidermidis after Single Course of Clarithromycin [PDF - 127 KB - 5 pages]
M. Sjölund et al.

We examined how a common therapy that includes clarithromycin affects normally colonizing Staphylococcus epidermidis. Samples from the nostrils of 5 patients receiving therapy were collected before, immediately after, 1 year after, and 4 years after treatment. From each patient and sample, S. epidermidis strains were isolated and analyzed for clarithromycin susceptibility and presence of the erm(C) gene. We show that macrolide-resistant strains of S. epidermidis were selected during therapy and that the same resistant strain may persist for 4 years, in the absence of further antimicrobial treatment.

EID Sjölund M, Tano E, Blaser MJ, Andersson DI, Engstrand L. Persistence of Resistant Staphylococcus epidermidis after Single Course of Clarithromycin. Emerg Infect Dis. 2005;11(9):1389-1393. https://doi.org/10.3201/eid1109.050124
AMA Sjölund M, Tano E, Blaser MJ, et al. Persistence of Resistant Staphylococcus epidermidis after Single Course of Clarithromycin. Emerging Infectious Diseases. 2005;11(9):1389-1393. doi:10.3201/eid1109.050124.
APA Sjölund, M., Tano, E., Blaser, M. J., Andersson, D. I., & Engstrand, L. (2005). Persistence of Resistant Staphylococcus epidermidis after Single Course of Clarithromycin. Emerging Infectious Diseases, 11(9), 1389-1393. https://doi.org/10.3201/eid1109.050124.

Simulated Anthrax Attacks and Syndromic Surveillance [PDF - 100 KB - 5 pages]
J. D. Nordin et al.

We measured sensitivity and timeliness of a syndromic surveillance system to detect bioterrorism events. A hypothetical anthrax release was modeled by using zip code population data, mall customer surveys, and membership information from HealthPartners Medical Group, which covers 9% of a metropolitan area population in Minnesota. For each infection level, 1,000 releases were simulated. Timing of increases in use of medical care was based on data from the Sverdlovsk, Russia, anthrax release. Cases from the simulated outbreak were added to actual respiratory visits recorded for those dates in HealthPartners Medical Group data. Analysis was done by using the space-time scan statistic. We evaluated the proportion of attacks detected at different attack rates and timeliness to detection. Timeliness and completeness of detection of events varied by rate of infection. First detection of events ranged from days 3 to 6. Similar modeling may be possible with other surveillance systems and should be a part of their evaluation.

EID Nordin JD, Goodman MJ, Kulldorff M, Ritzwoller DP, Abrams AM, Kleinman K, et al. Simulated Anthrax Attacks and Syndromic Surveillance. Emerg Infect Dis. 2005;11(9):1394-1398. https://doi.org/10.3201/eid1109.050223
AMA Nordin JD, Goodman MJ, Kulldorff M, et al. Simulated Anthrax Attacks and Syndromic Surveillance. Emerging Infectious Diseases. 2005;11(9):1394-1398. doi:10.3201/eid1109.050223.
APA Nordin, J. D., Goodman, M. J., Kulldorff, M., Ritzwoller, D. P., Abrams, A. M., Kleinman, K....Platt, R. (2005). Simulated Anthrax Attacks and Syndromic Surveillance. Emerging Infectious Diseases, 11(9), 1394-1398. https://doi.org/10.3201/eid1109.050223.

West Nile Virus–infected Mosquitoes, Louisiana, 2002 [PDF - 120 KB - 6 pages]
M. S. Godsey et al.

Human cases of West Nile virus (WNV) disease appeared in St. Tammany and Tangipahoa Parishes in southeastern Louisiana in June 2002. Cases peaked during July, then rapidly declined. We conducted mosquito collections from August 3 to August 15 at residences of patients with confirmed and suspected WNV disease to estimate species composition, relative abundance, and WNV infection rates. A total of 31,215 mosquitoes representing 25 species were collected by using primarily gravid traps and CO2-baited light traps. Mosquitoes containing WNV RNA were obtained from 5 of 11 confirmed case sites and from 1 of 3 sites with non-WNV disease. WNV RNA was detected in 9 mosquito pools, including 7 Culex quinquefasciatus, 1 Cx. salinarius, and 1 Coquillettidia perturbans. Mosquito infection rates among sites ranged from 0.8/1,000 to 10.9/1,000. Results suggest that Cx. quinquefasciatus was the primary epizootic/epidemic vector, with other species possibly playing a secondary role.

EID Godsey MS, Nasci R, Savage HM, Aspen S, King R, Powers AM, et al. West Nile Virus–infected Mosquitoes, Louisiana, 2002. Emerg Infect Dis. 2005;11(9):1399-1404. https://doi.org/10.3201/eid1109.040443
AMA Godsey MS, Nasci R, Savage HM, et al. West Nile Virus–infected Mosquitoes, Louisiana, 2002. Emerging Infectious Diseases. 2005;11(9):1399-1404. doi:10.3201/eid1109.040443.
APA Godsey, M. S., Nasci, R., Savage, H. M., Aspen, S., King, R., Powers, A. M....Palmisano, C. T. (2005). West Nile Virus–infected Mosquitoes, Louisiana, 2002. Emerging Infectious Diseases, 11(9), 1399-1404. https://doi.org/10.3201/eid1109.040443.

Legionellosis from Legionella pneumophila Serogroup 13 [PDF - 143 KB - 5 pages]
B. Faris et al.

We describe 4 cases of Legionella pneumophila serogroup 13–associated pneumonia. These cases originate from a broad geographic range that includes Scotland, Australia, and New Zealand. L. pneumophila serogroup 13 pneumonia has a clinically diverse spectrum that ranges from relatively mild, community-acquired pneumonia to potentially fatal severe pneumonia with multisystem organ failure. All cases were confirmed by culture and direct fluorescent antibody staining or indirect immunofluorescent antibody tests. Proven or putative sources of L. pneumophila serogroup 13 infections in 2 patients included a contaminated whirlpool spa filter and river water. An environmental source was not found in the remaining 2 cases; environmental cultures yielded only other L. pneumophila serogroups or nonpneumophila Legionella species. We describe the clinical and laboratory features of L. pneumophila serogroup 13 infections. L. pneumophila serogroup 13 pneumonia is rarely reported, but it may be an underrecognized pathogenic serogroup of L. pneumophila.

EID Faris B, Faris C, Schousboe M, Heath CH. Legionellosis from Legionella pneumophila Serogroup 13. Emerg Infect Dis. 2005;11(9):1405-1409. https://doi.org/10.3201/eid1109.050345
AMA Faris B, Faris C, Schousboe M, et al. Legionellosis from Legionella pneumophila Serogroup 13. Emerging Infectious Diseases. 2005;11(9):1405-1409. doi:10.3201/eid1109.050345.
APA Faris, B., Faris, C., Schousboe, M., & Heath, C. H. (2005). Legionellosis from Legionella pneumophila Serogroup 13. Emerging Infectious Diseases, 11(9), 1405-1409. https://doi.org/10.3201/eid1109.050345.

Malaria Attributable to the HIV-1 Epidemic, Sub-Saharan Africa [PDF - 401 KB - 10 pages]
E. L. Korenromp et al.

We assessed the impact of HIV-1 on malaria in the sub-Saharan African population. Relative risks for malaria in HIV-infected persons, derived from literature review, were applied to the HIV-infected population in each country, by age group, stratum of CD4 cell count, and urban versus rural residence. Distributions of CD4 counts among HIV-infected persons were modeled assuming a linear decline in CD4 after seroconversion. Averaged across 41 countries, the impact of HIV-1 was limited (although quantitatively uncertain) because of the different geographic distributions and contrasting age patterns of the 2 diseases. However, in Botswana, Zimbabwe, Swaziland, South Africa, and Namibia, the incidence of clinical malaria increased by <28% (95% confidence interval [CI] 14%–47%) and death increased by <114% (95% CI 37%–188%). These effects were due to high HIV-1 prevalence in rural areas and the locally unstable nature of malaria transmission that results in a high proportion of adult cases.

EID Korenromp EL, Williams BG, de Vlas SJ, Gouws E, Gilks CF, Ghys PD, et al. Malaria Attributable to the HIV-1 Epidemic, Sub-Saharan Africa. Emerg Infect Dis. 2005;11(9):1410-1419. https://doi.org/10.3201/eid1109.050337
AMA Korenromp EL, Williams BG, de Vlas SJ, et al. Malaria Attributable to the HIV-1 Epidemic, Sub-Saharan Africa. Emerging Infectious Diseases. 2005;11(9):1410-1419. doi:10.3201/eid1109.050337.
APA Korenromp, E. L., Williams, B. G., de Vlas, S. J., Gouws, E., Gilks, C. F., Ghys, P. D....Nahlen, B. L. (2005). Malaria Attributable to the HIV-1 Epidemic, Sub-Saharan Africa. Emerging Infectious Diseases, 11(9), 1410-1419. https://doi.org/10.3201/eid1109.050337.

Molecular Epidemiology of SARS-associated Coronavirus, Beijing [PDF - 219 KB - 5 pages]
W. Liu et al.

Single nucleotide variations (SNVs) at 5 loci (17564, 21721, 22222, 23823, and 27827) were used to define the molecular epidemiologic characteristics of severe acute respiratory syndrome–associated coronavirus (SARS-CoV) from Beijing patients. Five fragments targeted at the SNV loci were amplified directly from clinical samples by using reverse transcription–polymerase chain reaction (RT-PCR), before sequencing the amplified products. Analyses of 45 sequences obtained from 29 patients showed that the GGCTC motif dominated among samples collected from March to early April 2003; the TGTTT motif predominanted afterwards. The switch from GGCTC to TGTTT was observed among patients belonging to the same cluster, which ruled out the possibility of the coincidental superposition of 2 epidemics running in parallel in Beijing. The Beijing isolates underwent the same change pattern reported from Guangdong Province. The same series of mutations occurring in separate geographic locations and at different times suggests a dominant process of viral adaptation to the host.

EID Liu W, Tang F, Fontanet A, Zhan L, Wang T, Zhang P, et al. Molecular Epidemiology of SARS-associated Coronavirus, Beijing. Emerg Infect Dis. 2005;11(9):1420-1424. https://doi.org/10.3201/eid1109.040773
AMA Liu W, Tang F, Fontanet A, et al. Molecular Epidemiology of SARS-associated Coronavirus, Beijing. Emerging Infectious Diseases. 2005;11(9):1420-1424. doi:10.3201/eid1109.040773.
APA Liu, W., Tang, F., Fontanet, A., Zhan, L., Wang, T., Zhang, P....Cao, W. (2005). Molecular Epidemiology of SARS-associated Coronavirus, Beijing. Emerging Infectious Diseases, 11(9), 1420-1424. https://doi.org/10.3201/eid1109.040773.
Historical Review

Malaria in Kenya's Western Highlands [PDF - 470 KB - 8 pages]
G. Shanks et al.

Records from tea estates in the Kericho district in Kenya show that malaria reemerged in the 1980s. Renewed epidemic activity coincided with the emergence of chloroquine-resistant Plasmodium falciparum malaria and may have been triggered by the failure of antimalarial drugs. Meteorologic changes, population movements, degradation of health services, and changes in Anopheles vector populations are possible contributing factors. The highland malaria epidemics of the 1940s were stopped largely by sporontocidal drugs, and combination chemotherapy has recently limited transmission. Antimalarial drugs can limit the pool of gametocytes available to infect mosquitoes during the brief transmission season.

EID Shanks G, Hay SI, Omumbo JA, Snow RW. Malaria in Kenya's Western Highlands. Emerg Infect Dis. 2005;11(9):1425-1432. https://doi.org/10.3201/eid1109.041131
AMA Shanks G, Hay SI, Omumbo JA, et al. Malaria in Kenya's Western Highlands. Emerging Infectious Diseases. 2005;11(9):1425-1432. doi:10.3201/eid1109.041131.
APA Shanks, G., Hay, S. I., Omumbo, J. A., & Snow, R. W. (2005). Malaria in Kenya's Western Highlands. Emerging Infectious Diseases, 11(9), 1425-1432. https://doi.org/10.3201/eid1109.041131.
Dispatches

Protective Behavior and West Nile Virus Risk [PDF - 289 KB - 4 pages]
M. Loeb et al.

We conducted a cross-sectional, household survey in Oakville, Ontario, where an outbreak of West Nile virus (WNV) in 2002 led to an unprecedented number of cases of meningitis and encephalitis. Practicing >2 personal protective behavior traits reduced the risk for WNV infection by half.

EID Loeb M, Elliott SJ, Gibson B, Fearon M, Nosal R, Drebot M, et al. Protective Behavior and West Nile Virus Risk. Emerg Infect Dis. 2005;11(9):1433-1436. https://doi.org/10.3201/eid1109.041184
AMA Loeb M, Elliott SJ, Gibson B, et al. Protective Behavior and West Nile Virus Risk. Emerging Infectious Diseases. 2005;11(9):1433-1436. doi:10.3201/eid1109.041184.
APA Loeb, M., Elliott, S. J., Gibson, B., Fearon, M., Nosal, R., Drebot, M....Eyles, J. (2005). Protective Behavior and West Nile Virus Risk. Emerging Infectious Diseases, 11(9), 1433-1436. https://doi.org/10.3201/eid1109.041184.

West Nile Virus Detection in Kidney, Cloacal, and Nasopharyngeal Specimens [PDF - 94 KB - 3 pages]
O. A. Ohajuruka et al.

We compared kidney tissue samples and cloacal and nasopharyngeal swab samples from field-collected dead crows and blue jays for West Nile virus surveillance. Compared to tissue samples, 35% more swab samples were false negative. Swab samples were usually positive only when the corresponding tissue sample was strongly positive.

EID Ohajuruka OA, Berry RL, Grimes S, Farkas S. West Nile Virus Detection in Kidney, Cloacal, and Nasopharyngeal Specimens. Emerg Infect Dis. 2005;11(9):1437-1439. https://doi.org/10.3201/eid1109.050016
AMA Ohajuruka OA, Berry RL, Grimes S, et al. West Nile Virus Detection in Kidney, Cloacal, and Nasopharyngeal Specimens. Emerging Infectious Diseases. 2005;11(9):1437-1439. doi:10.3201/eid1109.050016.
APA Ohajuruka, O. A., Berry, R. L., Grimes, S., & Farkas, S. (2005). West Nile Virus Detection in Kidney, Cloacal, and Nasopharyngeal Specimens. Emerging Infectious Diseases, 11(9), 1437-1439. https://doi.org/10.3201/eid1109.050016.

Endemic Tularemia, Sweden, 2003 [PDF - 230 KB - 3 pages]
L. Payne et al.

Tularemia cases have been reported in Sweden since 1931, but no cyclical patterns can be identified. In 2003, the largest outbreak of tularemia since 1967 occurred, involving 698 cases. Increased reports were received from tularemia-nonendemic areas. Causal factors for an outbreak year and associated geographic distribution are not yet understood.

EID Payne L, Arneborn M, Tegnell A, Giesecke J. Endemic Tularemia, Sweden, 2003. Emerg Infect Dis. 2005;11(9):1440-1442. https://doi.org/10.3201/eid1109.041189
AMA Payne L, Arneborn M, Tegnell A, et al. Endemic Tularemia, Sweden, 2003. Emerging Infectious Diseases. 2005;11(9):1440-1442. doi:10.3201/eid1109.041189.
APA Payne, L., Arneborn, M., Tegnell, A., & Giesecke, J. (2005). Endemic Tularemia, Sweden, 2003. Emerging Infectious Diseases, 11(9), 1440-1442. https://doi.org/10.3201/eid1109.041189.

Chromobacterium violaceum in Siblings, Brazil [PDF - 152 KB - 3 pages]
I. Cristina de Siqueira et al.

Chromobacterium violaceum, a saprophyte bacterium found commonly in soil and water in tropical and subtropical climates, is a rare cause of severe, often fatal, human disease. We report 1 confirmed and 2 suspected cases of C. violaceum septicemia, with 2 fatalities, in siblings after recreational exposure in northeastern Brazil.

EID Cristina de Siqueira I, Dias JP, Ruf H, Ramos EG, Maciel E, Rolim A, et al. Chromobacterium violaceum in Siblings, Brazil. Emerg Infect Dis. 2005;11(9):1443-1445. https://doi.org/10.3201/eid1109.050278
AMA Cristina de Siqueira I, Dias JP, Ruf H, et al. Chromobacterium violaceum in Siblings, Brazil. Emerging Infectious Diseases. 2005;11(9):1443-1445. doi:10.3201/eid1109.050278.
APA Cristina de Siqueira, I., Dias, J. P., Ruf, H., Ramos, E. G., Maciel, E., Rolim, A....Silvany, C. (2005). Chromobacterium violaceum in Siblings, Brazil. Emerging Infectious Diseases, 11(9), 1443-1445. https://doi.org/10.3201/eid1109.050278.

Divergent HIV and Simian Immunodeficiency Virus Surveillance, Zaire [PDF - 174 KB - 3 pages]
A. Schaefer et al.

Recent HIV infection or divergent HIV or simian immunodeficiency virus (SIV) strains may be responsible for Western blot–indeterminate results on 70 serum samples from Zairian hospital employees that were reactive in an enzyme immunoassay. Using universal polymerase chain reaction HIV-1, HIV-2, and SIV primers, we detected 1 (1.4%) HIV-1 sequence. Except for 1 sample, no molecular evidence for unusual HIV- or SIV-like strains in this sampling was found.

EID Schaefer A, Robbins KE, Nzilambi E, St. Louis ME, Quinn TC, Folks TM, et al. Divergent HIV and Simian Immunodeficiency Virus Surveillance, Zaire. Emerg Infect Dis. 2005;11(9):1446-1448. https://doi.org/10.3201/eid1109.050179
AMA Schaefer A, Robbins KE, Nzilambi E, et al. Divergent HIV and Simian Immunodeficiency Virus Surveillance, Zaire. Emerging Infectious Diseases. 2005;11(9):1446-1448. doi:10.3201/eid1109.050179.
APA Schaefer, A., Robbins, K. E., Nzilambi, E., St. Louis, M. E., Quinn, T. C., Folks, T. M....Pieniazek, D. (2005). Divergent HIV and Simian Immunodeficiency Virus Surveillance, Zaire. Emerging Infectious Diseases, 11(9), 1446-1448. https://doi.org/10.3201/eid1109.050179.

West Nile Virus Isolation in Human and Mosquitoes, Mexico [PDF - 141 KB - 4 pages]
D. Elizondo-Quiroga et al.

West Nile virus has been isolated for the first time in Mexico, from a sick person and from mosquitoes (Culex quinquefasciatus). Partial sequencing and analysis of the 2 isolates indicate that they are genetically similar to other recent isolates from northern Mexico and the western United States.

EID Elizondo-Quiroga D, Davis C, Fernandez-Salas I, Escobar-Lopez R, Olmos D, Gastalum L, et al. West Nile Virus Isolation in Human and Mosquitoes, Mexico. Emerg Infect Dis. 2005;11(9):1449-1452. https://doi.org/10.3201/eid1109.050121
AMA Elizondo-Quiroga D, Davis C, Fernandez-Salas I, et al. West Nile Virus Isolation in Human and Mosquitoes, Mexico. Emerging Infectious Diseases. 2005;11(9):1449-1452. doi:10.3201/eid1109.050121.
APA Elizondo-Quiroga, D., Davis, C., Fernandez-Salas, I., Escobar-Lopez, R., Olmos, D., Gastalum, L....Tesh, R. B. (2005). West Nile Virus Isolation in Human and Mosquitoes, Mexico. Emerging Infectious Diseases, 11(9), 1449-1452. https://doi.org/10.3201/eid1109.050121.

Cyclosporiasis Outbreak, Indonesia [PDF - 125 KB - 3 pages]
M. Blans et al.

We describe an outbreak of Cyclospora cayetanensis infection among Dutch participants at a scientific meeting in September 2001 in Bogor, Indonesia. Fifty percent of the investigated participants were positive for C. cayetanensis. To our knowledge, this outbreak is the first caused by C. cayetanensis among susceptible persons in a disease-endemic area.

EID Blans M, Ridwan BU, Verweij JJ, Rozenberg-Arska M, Verhoef J. Cyclosporiasis Outbreak, Indonesia. Emerg Infect Dis. 2005;11(9):1453-1455. https://doi.org/10.3201/eid1109.040947
AMA Blans M, Ridwan BU, Verweij JJ, et al. Cyclosporiasis Outbreak, Indonesia. Emerging Infectious Diseases. 2005;11(9):1453-1455. doi:10.3201/eid1109.040947.
APA Blans, M., Ridwan, B. U., Verweij, J. J., Rozenberg-Arska, M., & Verhoef, J. (2005). Cyclosporiasis Outbreak, Indonesia. Emerging Infectious Diseases, 11(9), 1453-1455. https://doi.org/10.3201/eid1109.040947.

Plague from Eating Raw Camel Liver [PDF - 58 KB - 2 pages]
A. A. Saeed et al.

We investigated a cluster of 5 plague cases; the patients included 4 with severe pharyngitis and submandibular lymphadenitis. These 4 case-patients had eaten raw camel liver. Yersinia pestis was isolated from bone marrow of the camel and from jirds (Meriones libycus) and fleas (Xenopsylla cheopis) captured at the camel corral.

EID Saeed AA, Al-Hamdan NA, Fontaine RE. Plague from Eating Raw Camel Liver. Emerg Infect Dis. 2005;11(9):1456-1457. https://doi.org/10.3201/eid1109.050081
AMA Saeed AA, Al-Hamdan NA, Fontaine RE. Plague from Eating Raw Camel Liver. Emerging Infectious Diseases. 2005;11(9):1456-1457. doi:10.3201/eid1109.050081.
APA Saeed, A. A., Al-Hamdan, N. A., & Fontaine, R. E. (2005). Plague from Eating Raw Camel Liver. Emerging Infectious Diseases, 11(9), 1456-1457. https://doi.org/10.3201/eid1109.050081.

Melioidosis, Northeastern Brazil [PDF - 62 KB - 3 pages]
D. Rolim et al.

Melioidosis was first recognized in northeastern Brazil in 2003. Confirmation of additional cases from the 2003 cluster in Ceará, more recent cases in other districts, environmental isolation of Burkholderia pseudomallei, molecular confirmation and typing results, and positive serosurveillance specimens indicate that melioidosis is more widespread in northeastern Brazil than previously thought.

EID Rolim D, Vilar D, Sousa A, Miralles I, Almeida de Oliveira D, Harnett G, et al. Melioidosis, Northeastern Brazil. Emerg Infect Dis. 2005;11(9):1458-1460. https://doi.org/10.3201/eid1109.050493
AMA Rolim D, Vilar D, Sousa A, et al. Melioidosis, Northeastern Brazil. Emerging Infectious Diseases. 2005;11(9):1458-1460. doi:10.3201/eid1109.050493.
APA Rolim, D., Vilar, D., Sousa, A., Miralles, I., Almeida de Oliveira, D., Harnett, G....Inglis, T. (2005). Melioidosis, Northeastern Brazil. Emerging Infectious Diseases, 11(9), 1458-1460. https://doi.org/10.3201/eid1109.050493.

Multidrug-resistant Tuberculosis Detection, Latvia [PDF - 53 KB - 3 pages]
G. Skenders et al.

To improve multidrug-resistant tuberculosis (MDR-TB) detection, we successfully introduced the rpoB gene mutation line probe assay into the national laboratory in Latvia, a country with epidemic MDR-TB. The assay detected rifampin resistance with 91% sensitivity and 96% specificity within 1 to 5 days (vs. 12–47 days for BACTEC).

EID Skenders G, Fry AM, Prokopovica I, Greckoseja S, Broka L, Metchock B, et al. Multidrug-resistant Tuberculosis Detection, Latvia. Emerg Infect Dis. 2005;11(9):1461-1463. https://doi.org/10.3201/eid1109.041236
AMA Skenders G, Fry AM, Prokopovica I, et al. Multidrug-resistant Tuberculosis Detection, Latvia. Emerging Infectious Diseases. 2005;11(9):1461-1463. doi:10.3201/eid1109.041236.
APA Skenders, G., Fry, A. M., Prokopovica, I., Greckoseja, S., Broka, L., Metchock, B....Leimane, V. (2005). Multidrug-resistant Tuberculosis Detection, Latvia. Emerging Infectious Diseases, 11(9), 1461-1463. https://doi.org/10.3201/eid1109.041236.

β-Lactam Resistance and Enterobacteriaceae, United States [PDF - 97 KB - 3 pages]
J. M. Whichard et al.

Extended-spectrum cephalosporins (ESC) are an important drug class for treating severe Salmonella infections. We screened the human collection from the National Antimicrobial Resistance Monitoring System 2000 for ESC resistance mechanisms. Of non-Typhi Salmonella tested, 3.2% (44/1,378) contained blaCMY genes. Novel findings included blaCMY-positive Escherichia coli O157:H7 and a blaSHV-positive Salmonella isolate. CMY-positive isolates showed a ceftriaxone MIC >2 µg/mL.

EID Whichard JM, Joyce K, Fey PD, Nelson JA, Angulo FJ, Barrett TJ. β-Lactam Resistance and Enterobacteriaceae, United States. Emerg Infect Dis. 2005;11(9):1464-1466. https://doi.org/10.3201/eid1109.050182
AMA Whichard JM, Joyce K, Fey PD, et al. β-Lactam Resistance and Enterobacteriaceae, United States. Emerging Infectious Diseases. 2005;11(9):1464-1466. doi:10.3201/eid1109.050182.
APA Whichard, J. M., Joyce, K., Fey, P. D., Nelson, J. A., Angulo, F. J., & Barrett, T. J. (2005). β-Lactam Resistance and Enterobacteriaceae, United States. Emerging Infectious Diseases, 11(9), 1464-1466. https://doi.org/10.3201/eid1109.050182.

Perinatal Group B Streptococcal Disease Prevention, Minnesota [PDF - 51 KB - 3 pages]
C. A. Morin et al.

In 2002, revised guidelines for preventing perinatal group B streptococcal disease were published. In 2002, all Minnesota providers surveyed reported using a prevention policy. Most screen vaginal and rectal specimens at 34–37 weeks of gestation. The use of screening-based methods has increased dramatically since 1998.

EID Morin CA, White K, Schuchat A, Danila RN, Lynfield R. Perinatal Group B Streptococcal Disease Prevention, Minnesota. Emerg Infect Dis. 2005;11(9):1467-1469. https://doi.org/10.3201/eid1109.041109
AMA Morin CA, White K, Schuchat A, et al. Perinatal Group B Streptococcal Disease Prevention, Minnesota. Emerging Infectious Diseases. 2005;11(9):1467-1469. doi:10.3201/eid1109.041109.
APA Morin, C. A., White, K., Schuchat, A., Danila, R. N., & Lynfield, R. (2005). Perinatal Group B Streptococcal Disease Prevention, Minnesota. Emerging Infectious Diseases, 11(9), 1467-1469. https://doi.org/10.3201/eid1109.041109.

Characterizing Vancomycin-resistant Enterococci in Neonatal Intensive Care [PDF - 65 KB - 3 pages]
C. Sherer et al.

Repetitive sequence–based polymerase chain reaction fingerprinting was used to characterize 23 vancomycin-nonsusceptible enterococcal isolates from 2003 to 2004. Five genetically related clusters spanned geographically distinct referring centers. DNA fingerprinting showed infant-to-infant transmission from referring institutions. Thus, community healthcare facilities are a source of vancomycin-nonsusceptible enterococci and should be targeted for increased infection control efforts.

EID Sherer C, Sprague BM, Campos JM, Nambiar S, Temple R, Short B, et al. Characterizing Vancomycin-resistant Enterococci in Neonatal Intensive Care. Emerg Infect Dis. 2005;11(9):1470-1472. https://doi.org/10.3201/eid1109.050148
AMA Sherer C, Sprague BM, Campos JM, et al. Characterizing Vancomycin-resistant Enterococci in Neonatal Intensive Care. Emerging Infectious Diseases. 2005;11(9):1470-1472. doi:10.3201/eid1109.050148.
APA Sherer, C., Sprague, B. M., Campos, J. M., Nambiar, S., Temple, R., Short, B....Singh, N. (2005). Characterizing Vancomycin-resistant Enterococci in Neonatal Intensive Care. Emerging Infectious Diseases, 11(9), 1470-1472. https://doi.org/10.3201/eid1109.050148.

Human Infection with Rickettsia honei, Thailand [PDF - 69 KB - 3 pages]
J. Jiang et al.

Human spotted fever rickettsiosis was detected molecularly by 2 real-time polymerase chain reaction (PCR) assays performed on DNA extracted from a Thai patient's serum sample. Sequences of PCR amplicons from 5 rickettsial genes used for multilocus sequence typing were 100% identical with those deposited with GenBank for Rickettsia honei TT-118.

EID Jiang J, Sangkasuwan V, Lerdthusnee K, Sukwit S, Chuenchitra T, Rozmajzl PJ, et al. Human Infection with Rickettsia honei, Thailand. Emerg Infect Dis. 2005;11(9):1473-1475. https://doi.org/10.3201/eid1109.050011
AMA Jiang J, Sangkasuwan V, Lerdthusnee K, et al. Human Infection with Rickettsia honei, Thailand. Emerging Infectious Diseases. 2005;11(9):1473-1475. doi:10.3201/eid1109.050011.
APA Jiang, J., Sangkasuwan, V., Lerdthusnee, K., Sukwit, S., Chuenchitra, T., Rozmajzl, P. J....Richards, A. L. (2005). Human Infection with Rickettsia honei, Thailand. Emerging Infectious Diseases, 11(9), 1473-1475. https://doi.org/10.3201/eid1109.050011.

Streptococcus pneumoniae and Haemophilus influenzae type b Carriage, Central Asia [PDF - 188 KB - 4 pages]
S. H. Factor et al.

A study of children was conducted in 3 Central Asian Republics. Approximately half of the Streptococcus pneumoniae isolates were serotypes included in available vaccine formulations. Approximately 6% of children carried Haemophilus influenzae type b (Hib). Using pneumococcal and Hib conjugate vaccines may decrease illness in the Central Asian Republics.

EID Factor SH, LaClaire L, Bronsdon M, Suleymanova F, Altynbaeva G, Kadirov BA, et al. Streptococcus pneumoniae and Haemophilus influenzae type b Carriage, Central Asia. Emerg Infect Dis. 2005;11(9):1476-1479. https://doi.org/10.3201/eid1109.040798
AMA Factor SH, LaClaire L, Bronsdon M, et al. Streptococcus pneumoniae and Haemophilus influenzae type b Carriage, Central Asia. Emerging Infectious Diseases. 2005;11(9):1476-1479. doi:10.3201/eid1109.040798.
APA Factor, S. H., LaClaire, L., Bronsdon, M., Suleymanova, F., Altynbaeva, G., Kadirov, B. A....Chorba, T. (2005). Streptococcus pneumoniae and Haemophilus influenzae type b Carriage, Central Asia. Emerging Infectious Diseases, 11(9), 1476-1479. https://doi.org/10.3201/eid1109.040798.

Human Herpesvirus 8 and Pulmonary Hypertension [PDF - 166 KB - 3 pages]
E. Nicastri et al.

Human herpesvirus 8 (HHV-8) antibodies were detected in 1 of 33 patients with pulmonary hypertension (including in 1 of 16 with idiopathic pulmonary arterial hypertension), 5 of 29 with cystic fibrosis, and 3 of 13 with interstitial lung disease. No relationship between HHV-8 infection and pulmonary hypertension was found.

EID Nicastri E, Vizza C, Carletti F, Cicalini S, Badagliacca R, Poscia R, et al. Human Herpesvirus 8 and Pulmonary Hypertension. Emerg Infect Dis. 2005;11(9):1480-1482. https://doi.org/10.3201/eid1109.040880
AMA Nicastri E, Vizza C, Carletti F, et al. Human Herpesvirus 8 and Pulmonary Hypertension. Emerging Infectious Diseases. 2005;11(9):1480-1482. doi:10.3201/eid1109.040880.
APA Nicastri, E., Vizza, C., Carletti, F., Cicalini, S., Badagliacca, R., Poscia, R....Petrosillo, N. (2005). Human Herpesvirus 8 and Pulmonary Hypertension. Emerging Infectious Diseases, 11(9), 1480-1482. https://doi.org/10.3201/eid1109.040880.

Gram-positive Rod Surveillance for Early Anthrax Detection [PDF - 191 KB - 4 pages]
E. M. Begier et al.

Connecticut established telephone-based gram-positive rod (GPR) reporting primarily to detect inhalational anthrax cases more quickly. From March to December 2003, annualized incidence of blood isolates was 21.3/100,000 persons; reports included 293 Corynebacterium spp., 193 Bacillus spp., 73 Clostridium spp., 26 Lactobacillus spp., and 49 other genera. Around-the-clock GPR reporting has described GPR epidemiology and enhanced rapid communication with clinical laboratories.

EID Begier EM, Barrett NL, Mshar PA, Johnson DG, Hadler JL. Gram-positive Rod Surveillance for Early Anthrax Detection. Emerg Infect Dis. 2005;11(9):1483-1486. https://doi.org/10.3201/eid1109.041013
AMA Begier EM, Barrett NL, Mshar PA, et al. Gram-positive Rod Surveillance for Early Anthrax Detection. Emerging Infectious Diseases. 2005;11(9):1483-1486. doi:10.3201/eid1109.041013.
APA Begier, E. M., Barrett, N. L., Mshar, P. A., Johnson, D. G., & Hadler, J. L. (2005). Gram-positive Rod Surveillance for Early Anthrax Detection. Emerging Infectious Diseases, 11(9), 1483-1486. https://doi.org/10.3201/eid1109.041013.
Commentaries

Syndromic Surveillance in Bioterrorist Attacks [PDF - 173 KB - 2 pages]
A. F. Kaufmann et al.
EID Kaufmann AF, Pesik N, Meltzer MI. Syndromic Surveillance in Bioterrorist Attacks. Emerg Infect Dis. 2005;11(9):1487-1488. https://doi.org/10.3201/eid1109.050981
AMA Kaufmann AF, Pesik N, Meltzer MI. Syndromic Surveillance in Bioterrorist Attacks. Emerging Infectious Diseases. 2005;11(9):1487-1488. doi:10.3201/eid1109.050981.
APA Kaufmann, A. F., Pesik, N., & Meltzer, M. I. (2005). Syndromic Surveillance in Bioterrorist Attacks. Emerging Infectious Diseases, 11(9), 1487-1488. https://doi.org/10.3201/eid1109.050981.
Letters

Telithromycin-resistant Streptococcus pneumoniae [PDF - 26 KB - 2 pages]
F. W. Goldstein et al.
EID Goldstein FW, Vidal B, Kitzis MD. Telithromycin-resistant Streptococcus pneumoniae. Emerg Infect Dis. 2005;11(9):1489-1490. https://doi.org/10.3201/eid1109.050415
AMA Goldstein FW, Vidal B, Kitzis MD. Telithromycin-resistant Streptococcus pneumoniae. Emerging Infectious Diseases. 2005;11(9):1489-1490. doi:10.3201/eid1109.050415.
APA Goldstein, F. W., Vidal, B., & Kitzis, M. D. (2005). Telithromycin-resistant Streptococcus pneumoniae. Emerging Infectious Diseases, 11(9), 1489-1490. https://doi.org/10.3201/eid1109.050415.

Integrated Human-Animal Disease Surveillance [PDF - 54 KB - 2 pages]
W. A. Mauer and J. B. Kaneene
EID Mauer WA, Kaneene JB. Integrated Human-Animal Disease Surveillance. Emerg Infect Dis. 2005;11(9):1490-1491. https://doi.org/10.3201/eid1109.050180
AMA Mauer WA, Kaneene JB. Integrated Human-Animal Disease Surveillance. Emerging Infectious Diseases. 2005;11(9):1490-1491. doi:10.3201/eid1109.050180.
APA Mauer, W. A., & Kaneene, J. B. (2005). Integrated Human-Animal Disease Surveillance. Emerging Infectious Diseases, 11(9), 1490-1491. https://doi.org/10.3201/eid1109.050180.

VanB-VanC1 Enterococcus gallinarum, Italy [PDF - 58 KB - 2 pages]
C. Mammina et al.
EID Mammina C, Di Noto A, Costa A, Nastasi A. VanB-VanC1 Enterococcus gallinarum, Italy. Emerg Infect Dis. 2005;11(9):1491-1492. https://doi.org/10.3201/eid1109.050282
AMA Mammina C, Di Noto A, Costa A, et al. VanB-VanC1 Enterococcus gallinarum, Italy. Emerging Infectious Diseases. 2005;11(9):1491-1492. doi:10.3201/eid1109.050282.
APA Mammina, C., Di Noto, A., Costa, A., & Nastasi, A. (2005). VanB-VanC1 Enterococcus gallinarum, Italy. Emerging Infectious Diseases, 11(9), 1491-1492. https://doi.org/10.3201/eid1109.050282.

Empyema Thoracis from Salmonella Choleraesuis [PDF - 25 KB - 2 pages]
C. Lai et al.
EID Lai C, Lee L, Hsueh P, Yu C, Yang P. Empyema Thoracis from Salmonella Choleraesuis. Emerg Infect Dis. 2005;11(9):1493-1494. https://doi.org/10.3201/eid1109.050030
AMA Lai C, Lee L, Hsueh P, et al. Empyema Thoracis from Salmonella Choleraesuis. Emerging Infectious Diseases. 2005;11(9):1493-1494. doi:10.3201/eid1109.050030.
APA Lai, C., Lee, L., Hsueh, P., Yu, C., & Yang, P. (2005). Empyema Thoracis from Salmonella Choleraesuis. Emerging Infectious Diseases, 11(9), 1493-1494. https://doi.org/10.3201/eid1109.050030.

Asymptomatic Yersinia pestis Infection, China [PDF - 61 KB - 3 pages]
M. Li et al.
EID Li M, Song Y, Li B, Wang Z, Yang R, Jiang L, et al. Asymptomatic Yersinia pestis Infection, China. Emerg Infect Dis. 2005;11(9):1494-1496. https://doi.org/10.3201/eid1109.041147
AMA Li M, Song Y, Li B, et al. Asymptomatic Yersinia pestis Infection, China. Emerging Infectious Diseases. 2005;11(9):1494-1496. doi:10.3201/eid1109.041147.
APA Li, M., Song, Y., Li, B., Wang, Z., Yang, R., Jiang, L....Yang, R. (2005). Asymptomatic Yersinia pestis Infection, China. Emerging Infectious Diseases, 11(9), 1494-1496. https://doi.org/10.3201/eid1109.041147.

Sporotrichosis, Plain of Jars, Lao People's Democratic Republic [PDF - 46 KB - 2 pages]
P. N. Newton et al.
EID Newton PN, Chung W, Phetsouvanh R, White NJ. Sporotrichosis, Plain of Jars, Lao People's Democratic Republic. Emerg Infect Dis. 2005;11(9):1496-1497. https://doi.org/10.3201/eid1109.050240
AMA Newton PN, Chung W, Phetsouvanh R, et al. Sporotrichosis, Plain of Jars, Lao People's Democratic Republic. Emerging Infectious Diseases. 2005;11(9):1496-1497. doi:10.3201/eid1109.050240.
APA Newton, P. N., Chung, W., Phetsouvanh, R., & White, N. J. (2005). Sporotrichosis, Plain of Jars, Lao People's Democratic Republic. Emerging Infectious Diseases, 11(9), 1496-1497. https://doi.org/10.3201/eid1109.050240.

West Nile Virus Antibodies in Colombian Horses [PDF - 41 KB - 2 pages]
S. Mattar et al.
EID Mattar S, Edwards E, Laguado J, González M, Alvarez J, Komar N. West Nile Virus Antibodies in Colombian Horses. Emerg Infect Dis. 2005;11(9):1497-1498. https://doi.org/10.3201/eid1109.050426
AMA Mattar S, Edwards E, Laguado J, et al. West Nile Virus Antibodies in Colombian Horses. Emerging Infectious Diseases. 2005;11(9):1497-1498. doi:10.3201/eid1109.050426.
APA Mattar, S., Edwards, E., Laguado, J., González, M., Alvarez, J., & Komar, N. (2005). West Nile Virus Antibodies in Colombian Horses. Emerging Infectious Diseases, 11(9), 1497-1498. https://doi.org/10.3201/eid1109.050426.

Wild Poliovirus Type 1, Central African Republic [PDF - 72 KB - 2 pages]
I. Gouandjika-Vasilache et al.
EID Gouandjika-Vasilache I, Kipela J, Daba R, Mokwapi V, Nambozuina E, Cabore J, et al. Wild Poliovirus Type 1, Central African Republic. Emerg Infect Dis. 2005;11(9):1498-1499. https://doi.org/10.3201/eid1109.050517
AMA Gouandjika-Vasilache I, Kipela J, Daba R, et al. Wild Poliovirus Type 1, Central African Republic. Emerging Infectious Diseases. 2005;11(9):1498-1499. doi:10.3201/eid1109.050517.
APA Gouandjika-Vasilache, I., Kipela, J., Daba, R., Mokwapi, V., Nambozuina, E., Cabore, J....Menard, D. (2005). Wild Poliovirus Type 1, Central African Republic. Emerging Infectious Diseases, 11(9), 1498-1499. https://doi.org/10.3201/eid1109.050517.
About the Cover

Oneness, Complexity, and the Distribution of Disease [PDF - 69 KB - 2 pages]
P. Potter
EID Potter P. Oneness, Complexity, and the Distribution of Disease. Emerg Infect Dis. 2005;11(9):1500-1501. https://doi.org/10.3201/eid1109.ac1109
AMA Potter P. Oneness, Complexity, and the Distribution of Disease. Emerging Infectious Diseases. 2005;11(9):1500-1501. doi:10.3201/eid1109.ac1109.
APA Potter, P. (2005). Oneness, Complexity, and the Distribution of Disease. Emerging Infectious Diseases, 11(9), 1500-1501. https://doi.org/10.3201/eid1109.ac1109.
Etymologia

Etymologia: Rickettsia [PDF - 47 KB - 1 page]
EID Etymologia: Rickettsia . Emerg Infect Dis. 2005;11(9):1475. https://doi.org/10.3201/eid1109.et1109
AMA Etymologia: Rickettsia . Emerging Infectious Diseases. 2005;11(9):1475. doi:10.3201/eid1109.et1109.
APA (2005). Etymologia: Rickettsia . Emerging Infectious Diseases, 11(9), 1475. https://doi.org/10.3201/eid1109.et1109.
Page created: August 31, 2012
Page updated: August 31, 2012
Page reviewed: August 31, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
edit_01 ScholarOne Submission Portal
Issue Select
GO
GO

Spotlight Topics

 

Get Email Updates

To receive email updates about this page, enter your email address:

file_external